Immunizations during HIV infection

Current Opinion in Infectious Diseases

Volumn 11, Issue 1, 1998, Pages 17-21

  Glesby, Marshall J ^a  

^a Comm Research Initiative on AIDS ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; LIVE VACCINE;

DRUG EFFICACY; DRUG SAFETY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; REVIEW; SEROLOGY; VIRUS LOAD;

EID: 0031964903     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-199802000-00005     Document Type: Review

References (51)

1. Centers for Disease Control. General recommendations on immunization recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1994; 43(RR01):1-38.
2. Global Programme on AIDS and Expanded Programme on Immunization. Joint WHO/UNICEF statement on early immunization for HIV-infected children. Wkly Epidemiol Rec 1987; 40:297-299.
3. Expanded Programme on Immunization. Joint WHO/UNICEF statement on immunization and AIDS. Wkly Epidemiol Rec 1987; 62:53-54.
4. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen ISY. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990; 61:213-222.
5. Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993; 328:327-335.
6. Halsey NA, Henderson DA. HIV infection and immunization against other agents. N Engl J Med 1987; 316:683-685.
7. La Montagne JR. Immunization programs and human immunodeficiency virus. Rev Infect Dis 1989; 11 (suppl 3):S639-S643.
8. Ho DD. HIV-1 viraemia and influenza [letter]. Lancet 1992; 339:1549.
9. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272:1167-1170.
10. Saag MS, Holodniy M, Kuritzkes DR, O'Brien WA, Coombs R, Poscher ME, et al. HIV viral load markers in clinical practice. Nature Med 1996; 2:625-629.
11. Mellors JW, Muñoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126:946-954.
12. O'Brien WA, Grovit-Ferbas K, Namazi A, Ovcak-Derzic S, Wang H-J, Park J, et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 1995; 86:1082-1089.
13. Staprans SI, Hamilton BL, Follansbee SE, Elbeik T, Barbosa P, Grant RM, Feinberg MB. Activation of virus replication after vaccination of HIV-1-infected individuals. J Exp Med 1995; 182:1727-1737.
14. Voltersik RP, Axelsson M, Haaheim LR, Asjo B. Dynamics of HIV-1 replication following influenza vaccination of HIV+ individuals. Clin Exp Immunol 1996; 104:203-207.
15. Ramilo O, Hicks PJ, Borvak J, Gross LM, Zhong D, Squires JE, Vitetta ES. T cell activation and human immunodeficiency virus replication after influenza immunization of HIV infected children. Pediatr Infect Dis J 1996; 15:197-203.
16. Yerly S, Wunderli W, Wyler CA, Kaiser L, Hirschel B, Suter S, et al. Influenza immunization of HIV-1 infected patients does not increase HIV-1 viral load [letter]. AIDS 1994; 8:1503-1504.
17. Fowke KR, D'Amico R, Chernoff DN, Pottage JC, Benson AC, Sha BE, et al. Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients. AIDS 1997; 11:1013-1021.
18. Jackson CR, Vavro CL, Valentine ME, Penninglon KN, Lanier ER, Katz SL, Diliberti JH, et al. Effect of influenza immunization on immunologic and virologic characteristics of pediatric patients infected with human immunodeficiency virus. Pediatr Infect Dis J 1997; 16:200-204.
19. Donovan RM, Bush CE, Markowitz NP, Saravolatz LD. Changes in plasma HIV RNA levels and CD4 cell counts after vaccination of pediatric patients. AIDS 1997; 11:1054-1056.
20. Tasker S, O'Brien W, Rossetti R, Kaplan A, Olson P, Weiss P, Wallace M. Effects of influenza vaccination in HIV-infected patients: a double-blinded, placebo-controlled trial. Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1995; LB11 [abstract].
21. Glesby MJ, Hoover DR, Farzadegan H, Margolick JB, Saah AJ. The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study. J Infect Dis 1996; 174:1332-1336.
22. Brichacek B, Swindells S, Janoff EN, Pirrucello S, Stevenson M. Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine. J Infect Dis 1996; 174:1191-1199.
23. Stanley SK, Ostrowski MA, Justement JS, Gantt K, Hedayati S, Mannix M, et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med 1996; 334:1222-1230.
24. Cheeseman SH, Davaro RE, Ellison RT III. Hepatitis B vaccination and plasma HIV-1 RNA [letter]. N Engl J Med 1996; 334:1272.
25. Katzenstein TL, Gerstoft J, Nielsen H. Assessments of plasma HIV RNA and CD4 cell counts after combined pneumovax and tetanus toxoid vaccination: no detectable increase in HIV replication 6 weeks after immunization. Scand J Immunol 1996; 28:239-241.
26. Bush CE, Donovan RM, Markowitz NP, Kvale P, Saravolatz LD. A study of HIV RNA viral load in AIDS patients with bacterial pneumonia. J Acquir Immune Defic Syndr 1996; 13:23-26.
27. Bodsworth NJ, Neilsen GA, Donovan B. The effect of immunization with inactivated hepatitis A vaccine on the clinical course of HIV-1 infection: 1-year follow-up. AIDS 1997; 11:747-749.
28. Redfield RR, Wright DC, James WD, Jones TS, Brown C, Burke DS. Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N Engl J Med 1987; 316:673-676.
29. Onorato IM, Markowitz LE, Oxtoby MJ. Childhood immunization, vaccine-preventable diseases and infection with human immunodeficiency virus. Pediatr Infect Dis J 1988; 6:588-595.
30. Besnard M, Sauvion S, Offredo C, Gaudelus J, Gaillard J, Veber F, Blanche S. Bacillus Calmette-Guérin infection after vaccination of human immunodeficiency virus-infected children. Pediatr Infect Dis J 1993; 12:993-997.
31. Centers for Disease Control. Disseminated Mycobacterium bovis infection from BCG vaccination of a patient with acquired immunodeficiency syndrome. MMWR 1985; 34:227-228.
32. Ryder RW, Oxtoby MJ, Mvula M, Batter V, Baende E, Nsa W, et al. Safety and immunogenicity of bacille Calmette-Guérin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1. J Pediatr 1993; 122:697-702.
33. Lallemant-Le Coeur S, Lallemant M, Cheynier D, Nzingoula S, Drucker J, Larouze B. Bacillus Calmette-Guénn immunization in infants born to HIV-1 seropositive mothers. AIDS 1991; 5:195-199.
34. Anonymous. The role of BCG vaccine in the prevention and control of tuberculosis in the United States: a joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. MMWR 1996; 45:1-18.
35. Centers for Disease Control. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996; 45(RR11):1-25.
36. Centers for Disease Control. Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV infection, 1993. MMWR 1996; 45:603-606.
37. Kroon FP, van Dissel JT, de Jong JC, van Furth R. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS 1994; 8:469-476.
38. Ragni MV, Ruben FL, Winkelstein A, Spero JA, Bontempo FA, Lewis JH. Antibody responses to immunization of patients with hemophilia with and without evidence of human immunodeficiency virus (human T-lymphotropic virus type III) infection. J Lab Clin Med 1987; 109:545-549.
39. Steinhoff MC, Auerbach BS, Nelson KE, Vlahov D, Becker RL, Graham NMH, et al. Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection. N Engl J Med 1991; 325:1837-1842.
40. Nelson KE, Clements ML, Miotti P, Cohn S, Polk BF. The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines. Ann Intern Med 1988; 109:383-388.
41. Miotti PG, Nelson KE, Dallabetta GA, Farzadegan H, Margolick J, Clements ML. The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine. JAMA 1989; 262:779-783.
42. Vandenbruaene M, Colebunders R, Mascart-Lemone F, Haerden Y, Van Hove D, Peeters M, et al. Equal IgG antibody response to pneumococcal vaccination in all stages of human immunodeficiency virus disease. J Infect Dis 1995; 172:551-553.
43. Rodriguez-Barradas MC, Groover JE, Lacke CE, Gump DW, Lahart CJ, Pandey JP, Musher DM. IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response. J Infect Dis 1996; 173:1347-1353.
44. Keet IP, van Doomum G, Safary A, Coutinho RA. Insufficient response to hepatitis B vaccination in HIV-positive homosexual men [letter]. AIDS 1992; 6:509-510.
45. Glaser JB, Volpe S, Aguirre A, Simpkins H, Schiffman G. Zidovudine improves response to pneumococcal vaccine among persons with AIDS and AIDS-related complex. J Infect Dis 1991; 164:761-764.
46. Simberkoff MS, El Sadr W, Schiffman G, Rahal JJ Jr. Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with report of a pneumococcal vaccine failure. Am Rev Respir Dis 1984; 130:1174-1176.
47. Flegg PJ, Brettle RP, Bell JE, Bird AG, Busuttil A. Fatal pneumococcal meningitis in an HIV-infected drug user despite previous pneumococcal immunization. Int J STD AIDS 1994; 5:221-222.
48. Witt DJ, Craven DE, McCabe WR. Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Am J Med 1987; 82:900-906.
49. Janoff EN, O'Brien J, Thompson P, Ehret J, Meiklejohn G, Duvall G, Douglas JM. Streptococcus pneumoniae colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection. J Infect Dis 1993; 167:49-56.
50. Gebo KA, Moore RD, Keruly JC, Chaisson RE. Risk factors for pneumococcal disease in human immunodeficiency virus-infected patients. J Infect Dis 1996; 173:857-862.
51. Tasker S, Treanor J, Rossetti R, Paxton W, Wallace M. Whole virion influenza vaccine has protective efficacy in the setting of HIV infection. Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1996; 188 [abstract].